Apologies for following up my own post, but one conclusion from...

First 10615 Last

Share
Profile

Follow
KingBuzzo

352 Posts.

799

03/02/22

16:36

Post #: 59335870
Share

Originally posted by KingBuzzo: ↑

The real problem here is the lack of liquidity.

Looking (again) at IMU, though their market cap is approximately only 4 times bigger than RAC, their daily value of shares traded will typically well exceed $10 million. RAC on the other hand typically trades under $1million per day and some days struggles to crack $500,000 dollars worth (e.g. today).

So accounting for difference in market cap, on any average day IMU will have 3-6 times the liquidity (in dollar value) of RAC. Of course, in shares, relative liquidity is an order of magnitude higher again given the lower price per IMU share, but that's not as important assuming people are aware of the concept of market capitalisation (though it does appear that is a big assumption given some of the postings I've seen).

This lack of liquidity will make institutions wary of coming onto the register, as not only building a position is hard, but exiting that position is likely even harder given that would typically need to happen much faster if they've decided to exit. Even a lot of individuals here with a reasonable holding would face a similar issue... I'm certainly thankful I've no need or intent to sell my shares.

If RAC's liquidity were on par with IMU, BGs shares (or the subset he wants gone), would be history by now.

As to what the root cause of this is, I agree it's 1 and 2 as you've listed above... with the sticky longs in particular it would be interesting to know what the actual pool of available shares in RAC available on any typical day is, but with many shares "permanently" off market it would certainly be far fewer than the SOI. New interest in RAC to bid up the price would definitely help to loosen up some shares and improve liquidity, which in itself would bring in more interest. There's a bit of chicken and egg going here I think, and we need something to break the deadlock (likely positive news).

Expand

Apologies for following up my own post, but one conclusion from all this is that by removing significant liquidity from the market, "sticky longs" may be, somewhat paradoxically, one of the main factors keeping the share price lower than it otherwise would be.

RAC Price at posting: $3.00 Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 10,944 more messages in this thread...

First 10615 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.75		Change 0.010(0.57%)		Mkt cap ! $298.0M

Open	High	Low	Value	Volume
$1.73	$1.83	$1.73	$272.0K	152.3K

Buyers (Bids)

No.	Vol.	Price($)
1	9998	$1.75

Sellers (Offers)

Price($)	Vol.	No.
$1.79	2000	1

View Market Depth

No.	Vol.	Price($)
1	9998	1.750
1	7599	1.730
1	581	1.720
3	11557	1.710
4	46280	1.700

Price($)	Vol.	No.
1.790	2000	1
1.830	44030	2
1.840	10500	2
1.850	14500	3
1.860	949	2

Last trade - 16.10pm 09/07/2024 (20 minute delay)

RAC (ASX) Chart

Apologies for following up my own post, but one conclusion from...

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Apologies for following up my own post, but one conclusion from...

Top Stories

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News